Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Karolinska Institutet

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1810-01-01

Employees: 1K

Market Cap: -

Website: http://www.ki.se

Clinical Trials

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Phase 2

Withdrawn

Conditions: Pancreatic Neoplasms
Biliary Tract Neoplasms
Duodenal Neoplasms

First Posted Date: 2007-06-19

Last Posted Date: 2013-04-12

Lead Sponsor: Karolinska Institutet

Registration Number: NCT00487851

Locations: 🇸🇪
Karolinksa university hospital, Huddinge, Sweden

Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting

Phase 1

Completed

Conditions: Myocardial Reperfusion Injury
Atrial Fibrillation

Interventions: Drug: propofol
Drug: Sevoflurane

First Posted Date: 2007-06-11

Last Posted Date: 2010-05-20

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 100

Registration Number: NCT00484575

Locations: 🇸🇪
Karolinska University Hospital Solna, Cardiothoracic Intensive Care Unit, Stockholm, Sweden

Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes

Phase 3

Conditions: Metabolic Syndrome

Interventions: Drug: Placebo
Drug: Transdermal testosterone therapy

First Posted Date: 2007-05-28

Last Posted Date: 2008-05-07

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 176

Registration Number: NCT00479609

Locations: 🇸🇪
Karolinska University Hospital, Stockholm, Sweden

Study of the Impact of Virtual Patient Designs on the Reasoning Pattern and Therapeutic Decision Making

Not Applicable

Completed

Conditions: Computer-Assisted
Decision Making

First Posted Date: 2007-05-17

Last Posted Date: 2007-05-17

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 58

Registration Number: NCT00474474

Locations: 🇸🇪
School of dentistry, Karolinska Institutet, Stockholm, Sweden

Treatment With TNF Blockade, Infliximab, in Patients With Myositis

Phase 2

Completed

Conditions: Refractory Myositis

First Posted Date: 2007-03-05

Last Posted Date: 2007-03-05

Lead Sponsor: Karolinska Institutet

Registration Number: NCT00443222

Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)

Not Applicable

Completed

Conditions: Allergic Asthma

Interventions: Drug: Single corticosteroid inhalers and Singulair

First Posted Date: 2007-01-11

Last Posted Date: 2012-08-15

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 187

Registration Number: NCT00421018

Locations: 🇸🇪
Runby Primary Health Care Center, Upplands Väsby, Sweden

Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia

Phase 4

Terminated

Conditions: Critical Limb Ischemia
Ischemia
Arterial Occlusive Disease
Pain

Interventions: Drug: placebo
Drug: pregabalin

First Posted Date: 2006-11-27

Last Posted Date: 2018-06-15

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 18

Registration Number: NCT00403780

Locations: 🇸🇪
Deptartment of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
🇸🇪
Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden
🇸🇪
Deptartment of Surgery, South Hospital, Stockholm, Sweden

Safety Study of Pelvic Organ Prolapse Repair Using Transvaginal Mesh

Phase 2

Completed

Conditions: Pelvic Organ Prolapse

First Posted Date: 2006-11-22

Last Posted Date: 2007-11-14

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 250

Registration Number: NCT00402844

Locations: 🇩🇰
Nyköbing Hospital, Nyköbing, Denmark
🇩🇰
Skejby Hospital, Skejby, Denmark
🇫🇮
Jorvi Hospital, Jorvi, Finland

and more 23 locations

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Not Applicable

Completed

Conditions: Glioblastoma Multiforme
Cytomegalovirus Infection

Interventions: Drug: Valganciclovir (Valcyte)
Other: Placebo

First Posted Date: 2006-11-16

Last Posted Date: 2021-03-01

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 42

Registration Number: NCT00400322

Locations: 🇸🇪
Department of neurosurgery, Karolinska University Hospital, Solna, Stockholm, Sweden
🇸🇪
Department of Oncology, Norrland University Hospital, Umea, Sweden
🇸🇪
Department of Oncology, Akademiska Hospital, Uppsala, Sweden

Irbesartan and Atenolol in Hypertensive Heart Disease

Phase 2

Completed

Conditions: Hypertension

Interventions: Drug: Irbesartan
Drug: Atenolol

First Posted Date: 2006-10-18

Last Posted Date: 2015-05-05

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 115

Registration Number: NCT00389168

Locations: 🇸🇪
Karolinska Institutet, Daprtment of Clinical Sciences, Danderyd Hospital, Cardiovascular Research Laboratory, Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy